dc.contributor.author |
Frumusache, Alesea |
|
dc.contributor.author |
Testemițanu, Olga |
|
dc.date.accessioned |
2021-12-21T13:35:19Z |
|
dc.date.available |
2021-12-21T13:35:19Z |
|
dc.date.issued |
2014 |
|
dc.identifier.citation |
FRUMUSACHE, Alesea, TESTEMITANU, Olga. The role of kinetotherapy in patients with rheumatic heart disease. In: MedEspera: the 5th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2014, p. 67. |
en_US |
dc.identifier.uri |
http://repository.usmf.md/handle/20.500.12710/19487 |
|
dc.description |
State University of Medicine and Pharmacy “Nicolae Testemitanu”, Chişinău, Republic of Moldova |
en_US |
dc.description.abstract |
Introduction: Rheumatic heart disease presents further an increased mortality, although their
prevalence in industrialized countries decreases. However, remains a current topic for the
economically less developed regions with the ineffectiveness of preventive methods applied to
microbial agents. European guidelines dedicated to the management of patients with rheumatic
heart disease are limited to recommendations regarding patient education, disease prevention and
behavior, and recommendations to anticoagulant therapy.
Purpose and Objectives: Estimation and evaluation of therapeutic efficacy of kinetotherapy
in the complex treatment of patients with rheumatic heart disease.
Materials and methods: Our study is based on 61 patients with rheumatic heart disease who
were investigated in the complex by tools objectification: oxygen saturation, PSQIII general
satisfaction, global assessment by the patient and physician PGA / MDGA, were treated and
trained. Only 38 of them received physical therapy.
Results: Our study relieved the predominance of women in 68.8%, mean age 54.6 years, 61% was
noticed varying degrees of obesity, half of the patients present different degree of disability and only 5
patients are capable to working. Clinical dates attest different stages of dyspnea (100%), palpitations
followed by 72.13% and 57.37% with fatigue. At baseline, heart failure prevalent NYHA class 111
according to 64% and finally the 40% grade III and 42% grade II. The patients from the study with
kinetotherapy appropriated necessary methods like (descending abdominal breathing / chest and climbing
stairs, restoring elements of breath), and training self-management of the disease. We evaluated the
efficacy of complex treatment in combination with kinetotherapy in patients with rheumatic heart disease
and we proved the superiority versus no kinetotherapy, translated by reducing the degree of dyspnea
100%, global assessment of disease by the patient 34.2 mm and physician 33.5 mm. Analysis of overall
satisfaction by PSQIII caused an elevated issues and interpersonal communication, time spent with the
doctor from the average values in the population, but financial problem persist.
Conclusion: Patients who received kinetotherapy prove the increased level of general
satisfaction, the decrease of global assessment by patient and the increase of the compliance to the
received treatment versus those without kinetotherapy demonstrated by functional methods. |
en_US |
dc.language.iso |
en |
en_US |
dc.publisher |
Ministry of Health of the Republic of Moldova, State Medical and Pharmaceutical University Nicolae Testemitanu, Medical Students and Residents Association |
en_US |
dc.relation.ispartof |
MedEspera: The 5th International Medical Congress for Students and Young Doctors, May 14-17, 2014, Chisinau, Republic of Moldova |
en_US |
dc.subject |
Rheumatic heart disease |
en_US |
dc.subject |
kinetotherapy |
en_US |
dc.title |
The role of kinetotherapy in patients with rheumatic heart disease |
en_US |
dc.type |
Other |
en_US |